The Biden administration on Friday released the next round of prescription drugs selected for Medicare price negotiations, ...
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
Current laws and regulations are not enough to protect Americans from the risks of compounded versions of popular weight loss ...
Eli Lilly & Co. ( LLY) thinks its next experimental weight-loss pill could get approved as soon as early 2026.
A new trend gaining popularity among people ... prescribed for managing type 2 diabetes and aiding weight loss, experts ...
Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...
Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...
A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.